Triple-Negative Breast Cancer (TNBC) Completed Phase 2 / 3 Trials for Carboplatin (DB00958)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01881230Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)Treatment